Study of WGb-0301 for relapsed immune diseases
Part of Immune system & allergy clinical trials.
This trial tests a new medicine called WGb-0301 for people with relapsed or hard-to-treat immune diseases like lupus, autoimmune hepatitis, inflammatory muscle disease, or scleroderma. It may help when standard treatments have stopped working.
Summary written for real people, not researchers, by Clin2.
Who can take part
- You are between 18 and 70 years old.
- You have a relapsed or hard-to-treat immune disease like lupus, autoimmune hepatitis, inflammatory muscle disease, or scleroderma.
- You are able to care for yourself (KPS score > 60) and expected to live at least 6 months.
- You agree to use reliable birth control during the study and for 30 days after stopping the drug (if applicable).
- You do not have active infections, uncontrolled heart problems, or other untreated cancers.
- You have not had a live vaccine or protein-based vaccine in the last 30 days.
Quick eligibility check
Answer a few plain-language questions, based on this study's own requirements, to get a preliminary sense of fit.
Similar studies
Other trials that look related to this one.
This trial tests if a new cell therapy called GT719 can help people with moderate to severe lupus, inflammatory myopathy, or systemic sclerosis that hasn't gotten better with standard treatments. It aims to find a new option for those who have not responded well to usual medications.
This trial tests a new type of medicine (ABO2203) that trains your immune system to attack the cells causing your autoimmune disease. It's for people who haven't gotten better with standard treatments.
This trial tests a new treatment, WGb-0301, for people with B-cell lymphoma or leukemia that has come back or not responded to other therapies. It aims to see if this therapy can help when standard options are no longer working.
This trial tests a new therapy called WGb-0302 for people with multiple myeloma that has come back or is not responding to other treatments. It aims to see if this therapy can help control the cancer.
This trial tests an experimental cell therapy (GT719) for people with autoimmune diseases like lupus, inflammatory myositis, or systemic sclerosis that have not responded well to other treatments. It aims to see if this therapy can help control the disease.
This study tests a new injection called MTM-H-001 to treat autoimmune diseases where the body's B cells attack itself (like rheumatoid arthritis or lupus). The trial aims to see if this treatment is safe and effective for adults.
Hear when a new Autoimmune Diseases trial opens
We’ll email you when one opens — at most once a week, no account needed, unsubscribe anytime.